Time-course experiments unveiled that the two compounds impeded the accumulation of viral genomic RNA primarily at later stages of infection, aligning with their capacity to hinder NS2B–NS3 protease activity, polyprotein processing and viral genomic RNA replication. This evidence concerns the gene KRAS and infection.